Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 1/2 1

Status

Completed 12Terminated 6Recruiting 5Unknown 4Not yet recruiting 3Active not recruiting 1

Sponsor Class

OTHER 2OTHER_GOV 1INDUSTRY 1

Study Type

Interventional 4

Sponsor

Cancer Type

Gastrointestinal 3Tumor-Agnostic 1

Conditions

Breast Neoplasms 64Colorectal Neoplasms 58Rectal Neoplasms 46Stomach Neoplasms 44Neoplasm Metastasis 16Pancreatic Neoplasms 15Colonic Neoplasms 13Triple Negative Breast Neoplasms 11Neoplasms 11Esophageal Neoplasms 9Nasopharyngeal Carcinoma 8Locally Advanced Rectal Cancer 7Esophageal Squamous Cell Carcinoma 7Cholangiocarcinoma 6Biliary Tract Neoplasms 6Carcinoma, Hepatocellular 5HER2 Positive Metastatic Breast Cancer 4Colorectal Cancer Metastatic 4Adenocarcinoma 4Solid Tumor 3Recurrence 3Gallbladder Neoplasms 3Anus Neoplasms 3Advanced Breast Cancer 3Squamous Cell Carcinoma of Head and Neck 2Solid Tumors 2Neuroendocrine Tumors 2Locally Advanced Colon Cancer 2Hyperthermia 2Head and Neck Neoplasms 2

Interventions

Docetaxel 5Pemetrexed 4Capecitabine 4pembrolizumab 3Oxaliplatin 3icotinib 2Radiation 2Paclitaxel 2Gemcitabine 2Gefitinib 2Fluorouracil 2Drug Therapy 2Chemoradiotherapy 2Carboplatin 2sintilimab 1rucaparib 1regorafenib 1olaparib 1lenvatinib 1iron isomaltoside 1000 1iopromide 1gluconic acid 1elemene 1capecitabine-irinotecan combination 1aumolertinib 1anlotinib 1aflutinib 1XELOX 1Telemedicine 1Surveys and Questionnaires 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Unknown × Adenocarcinoma × Capecitabine × Clear all
NCT05964543 2023-07-28

The Safety and Efficacy of Q-1802 Combined With XELOX in Gastrointestinal Tumors

QureBio Ltd.

Phase 1/2 Unknown
72 enrolled
Tumor-Agnostic

Adenocarcinoma, Neoplasms

NCT01952951 2017-09-13

PREPARE

National Cancer Center, Korea

Phase 2 Unknown
110 enrolled
Gastrointestinal

Adenocarcinoma, Rectal Neoplasms

NCT01552967 2012-03-28

mXELOX

Sixth Affiliated Hospital, Sun Yat-sen University

Phase 2 Unknown
30 enrolled
Gastrointestinal

Adenocarcinoma, Colorectal Neoplasms

NCT00669370 2008-04-30

GAST-TaxXel

University of Turku

Phase 2 Unknown
50 enrolled
Gastrointestinal

Adenocarcinoma, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡